These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 26498027)
1. Emerging roles of podoplanin in vascular development and homeostasis. Pan Y; Xia L Front Med; 2015 Dec; 9(4):421-30. PubMed ID: 26498027 [TBL] [Abstract][Full Text] [Related]
2. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood. Suzuki-Inoue K; Osada M; Ozaki Y J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039 [TBL] [Abstract][Full Text] [Related]
3. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Herzog BH; Fu J; Wilson SJ; Hess PR; Sen A; McDaniel JM; Pan Y; Sheng M; Yago T; Silasi-Mansat R; McGee S; May F; Nieswandt B; Morris AJ; Lupu F; Coughlin SR; McEver RP; Chen H; Kahn ML; Xia L Nature; 2013 Oct; 502(7469):105-9. PubMed ID: 23995678 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of podoplanin expression by Prox1 in lymphatic endothelial cells. Pan Y; Wang WD; Yago T Microvasc Res; 2014 Jul; 94():96-102. PubMed ID: 24944097 [TBL] [Abstract][Full Text] [Related]
5. A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology. Suzuki-Inoue K; Tsukiji N Curr Opin Hematol; 2024 May; 31(3):130-139. PubMed ID: 38359177 [TBL] [Abstract][Full Text] [Related]
6. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity. Bianchi R; Fischer E; Yuen D; Ernst E; Ochsenbein AM; Chen L; Otto VI; Detmar M J Biol Chem; 2014 Jul; 289(30):21016-27. PubMed ID: 24907275 [TBL] [Abstract][Full Text] [Related]
7. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Acton SE; Astarita JL; Malhotra D; Lukacs-Kornek V; Franz B; Hess PR; Jakus Z; Kuligowski M; Fletcher AL; Elpek KG; Bellemare-Pelletier A; Sceats L; Reynoso ED; Gonzalez SF; Graham DB; Chang J; Peters A; Woodruff M; Kim YA; Swat W; Morita T; Kuchroo V; Carroll MC; Kahn ML; Wucherpfennig KW; Turley SJ Immunity; 2012 Aug; 37(2):276-89. PubMed ID: 22884313 [TBL] [Abstract][Full Text] [Related]
8. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774 [TBL] [Abstract][Full Text] [Related]
9. Podoplanin requires sialylated O-glycans for stable expression on lymphatic endothelial cells and for interaction with platelets. Pan Y; Yago T; Fu J; Herzog B; McDaniel JM; Mehta-D'Souza P; Cai X; Ruan C; McEver RP; West C; Dai K; Chen H; Xia L Blood; 2014 Dec; 124(24):3656-65. PubMed ID: 25336627 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Acton SE; Farrugia AJ; Astarita JL; Mourão-Sá D; Jenkins RP; Nye E; Hooper S; van Blijswijk J; Rogers NC; Snelgrove KJ; Rosewell I; Moita LF; Stamp G; Turley SJ; Sahai E; Reis e Sousa C Nature; 2014 Oct; 514(7523):498-502. PubMed ID: 25341788 [TBL] [Abstract][Full Text] [Related]
11. Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis. Chen Y; Keskin D; Sugimoto H; Kanasaki K; Phillips PE; Bizarro L; Sharpe A; LeBleu VS; Kalluri R PLoS Biol; 2018 Dec; 16(12):e2005907. PubMed ID: 30592710 [TBL] [Abstract][Full Text] [Related]
12. The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Astarita JL; Cremasco V; Fu J; Darnell MC; Peck JR; Nieves-Bonilla JM; Song K; Kondo Y; Woodruff MC; Gogineni A; Onder L; Ludewig B; Weimer RM; Carroll MC; Mooney DJ; Xia L; Turley SJ Nat Immunol; 2015 Jan; 16(1):75-84. PubMed ID: 25347465 [TBL] [Abstract][Full Text] [Related]
13. Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer. Bieniasz-Krzywiec P; Martín-Pérez R; Ehling M; García-Caballero M; Pinioti S; Pretto S; Kroes R; Aldeni C; Di Matteo M; Prenen H; Tribulatti MV; Campetella O; Smeets A; Noel A; Floris G; Van Ginderachter JA; Mazzone M Cell Metab; 2019 Nov; 30(5):917-936.e10. PubMed ID: 31447322 [TBL] [Abstract][Full Text] [Related]
14. Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes. Bianchi R; Russo E; Bachmann SB; Proulx ST; Sesartic M; Smaadahl N; Watson SP; Buckley CD; Halin C; Detmar M Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):108-117. PubMed ID: 27810998 [TBL] [Abstract][Full Text] [Related]
15. Platelets in lymph vessel development and integrity. Watson SP; Lowe K; Finney BA Adv Anat Embryol Cell Biol; 2014; 214():93-105. PubMed ID: 24276889 [TBL] [Abstract][Full Text] [Related]
17. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. Osada M; Inoue O; Ding G; Shirai T; Ichise H; Hirayama K; Takano K; Yatomi Y; Hirashima M; Fujii H; Suzuki-Inoue K; Ozaki Y J Biol Chem; 2012 Jun; 287(26):22241-52. PubMed ID: 22556408 [TBL] [Abstract][Full Text] [Related]
18. Modulation of VEGF-induced migration and network formation by lymphatic endothelial cells: Roles of platelets and podoplanin. Langan SA; Navarro-Núñez L; Watson SP; Nash GB Platelets; 2018 Jul; 29(5):486-495. PubMed ID: 28727496 [TBL] [Abstract][Full Text] [Related]
19. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. Suzuki-Inoue K J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546 [TBL] [Abstract][Full Text] [Related]
20. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application]. Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]